Lab Train Me Video – What’s New in Holotype HLA V.2 Protocol?

13/07/2017

Join Omixon’s Efi Melista for a detailed explanation on what’s new in our Holotype HLA V.2 Protocol. We are happy to present faster and simpler version of the original, V.1 protocol to make HLA typing by NGS faster and easier for everyone. To watch all our previous Train Me...

New Release – HLA Twin RUO 2.1.2

29/06/2017

Omixon has recently announced a major release for HLA Twin, version 2.1.2. – the world’s most accurate, high throughput HLA genotyping software. Thanks to all your feedback and comments, we are delighted to announce a range of new features below: HML improvements New pairwise alignment base...

Omixon Celebrates a Successful EFI 2017

21/06/2017

Thank you to all our friends, customers, co-vendors and distributors for visiting our wonderful new booth, joining our events and just generally hanging out at the 31st annual EFI Meeting in Mannheim, Germany between 30 May-02 June, 2017! Omixon conducted a range of activities, including our very first Distributor...

Human Leukocyte Antigen as a Critical Biomarker for the Adoption of Novel Immunotherapies of Cancer

15/06/2017

– Written by Attila Bérces (Founder and Chairman, Omixon) While the role of HLA has been demonstrated in over hundred diseases, its clinical utility and impact outside transplantation has been limited. Transplantation is still the dominant driver for the clinical HLA typing market. A new therapeutic paradigm in cancer...

High-throughput Automation of Holotype HLA in Routine HLA Genotyping at the EFI Annual Meeting 2017

29/05/2017

Omixon announce today that Holotype HLA™ and other Omixon products will be featured in 12 poster presentations produced by Holotype customers at the annual meeting of the European Federation for Immunogenetics (EFI) in Mannheim, Germany. Additionally, Omixon’s Lunch Symposium on Wednesday will focus on Automated HLA Typing by...